Explore the science, products and technologies behind Concept Medical Group. One mobile-first destination for healthcare professionals and professional audiences at every conference.
See the Science.
Explore the Portfolio.
Discover the Group.
From SirPAD / NEJM evidence to Nanolute technology and Envision Scientific manufacturing. A smarter way to explore Concept Medical Group at conference.
Latest landmark clinical evidence from SirPAD, SIRONA, EASTBOURNE and TRANSFORM II supporting the MagicTouch platform across PAD and coronary artery disease.
Primary results confirm the safety and efficacy of the sirolimus-coated balloon in peripheral arterial disease. Published in the NEJM. Primary endpoint met.
Head-to-head RCT in 482 patients across 25 sites. MagicTouch PTA achieved 73.8% primary patency vs 75% for paclitaxel DCBs (1.2% difference), meeting the non-inferiority endpoint. No significant difference in cdTLR at 12 months. 89% of patients improved by one or more Rutherford stage. Presented at TCT USA 2024 LBCT.
Prospective registry evaluating MagicTouch SCB in an all-comer coronary artery disease population. Provides real-world evidence across a broad spectrum of lesion types and patient profiles. Published in Eurointervention.
One of the largest global DCB RCTs. Enrollment of 1,832 patients completed June 2025 across 52 centres in Europe, Asia and South America. Compares MagicTouch SCB vs everolimus-eluting stent in de novo coronary lesions. Primary endpoint: Target Lesion Failure at 12 months, non-inferiority design. Follow-up up to 60 months. NCT04893291.
Explore the full Concept Medical Group portfolio across coronary, peripheral, access and specialty use cases.
World's first Sirolimus Coated Balloon for targeted sub-micron drug delivery across the CAD spectrum. Indicated for ISR, small vessels, bifurcation and de-novo lesions. 2 US FDA IDE Approval for Small Vessels & In-Stent Restenosis Indications.
View product →Sirolimus-coated balloon for stenotic lesions of dysfunctional AV fistula and graft. Dedicated clinical trials and investigator programme for dialysis access patients.
View product →Sirolimus-coated balloon for vasculogenic erectile dysfunction in de-novo and restenotic lesions. A specialty innovation extending the MagicTouch platform.
View product →Peripheral sirolimus-coated balloon for SFA, BTK, popliteal and iliac arteries. SirPAD primary results published in NEJM 2026 confirming safety and efficacy in PAD.
View product →Sirolimus-eluting stent for diabetes mellitus, acute myocardial infarction and symptomatic CAD. Powered by the Envisolution platform for better bioavailability and long-term outcomes.
View product →Polymer-free sirolimus-eluting stent with fusion-coating. Active STARS DAPT programme with first patient enrolled January 2026. Designed for reduced DAPT duration and improved healing.
View product →Broad peripheral angioplasty solution including SFA, BTK and AV dialysis fistulae. Designed as a reliable adjunct dilatation device for complex peripheral and access workflows.
View product →Rapid exchange thrombus aspiration catheter for central and peripheral circulatory use in PTCA, PTA and stenting procedures. Adjunct support across multiple indications.
View product →Proprietary drug-delivery platforms connecting clinical intent with precise drug transfer, retention and healing behaviour.
Advanced drug delivery technology enabling sustained, homogeneous sirolimus transfer from non-implantable balloon surfaces. Unique circumferential coating for 100% surface area coverage.
Proprietary stent coating providing better bioavailability of sirolimus, supporting healing behaviour and long-term outcomes across the Abluminus DES family.
The group's manufacturing establishment responsible for production scale, quality systems, regulatory compliance and controlled facility operations across all product families.
Manufacturing scale, quality systems and controlled facility access underpinning the Concept Medical Group portfolio.
Manufacturing establishment behind Concept Medical Group responsible for production scale, quality systems, regulatory compliance and controlled facility operations across DCB and DES product families.
12-hour or 24-hour time-limited virtual access to the manufacturing environment for registered professional visitors attending this conference.
Register interest in Concept Classroom or download product and clinical documentation.
An education-first format connecting science, technique and applied learning for healthcare professionals. Register interest to receive updates at launch.
Access clinical updates, product brochures and approved publications for MagicTouch and Abluminus families.
Book a meeting, reach medical information or connect with the right representative for your region.
Meet a Concept Medical representative at the conference or schedule a follow-up session post-event.
Reach the Concept Medical team directly for product queries, medical information or documentation requests.
Connect directly with our team for product details, clinical questions, or to be put in touch with the right person in your region.
An education-first format connecting science, technique and applied learning for healthcare professionals. Register your interest to be the first to know when Concept Classroom launches.